论文部分内容阅读
目的探讨用米索前列醇(以下简称米索)快速减少剖宫产术后出血的临床效果。方法选择有产后出血高危因素的孕妇200例,其中100例在剖宫产术中胎儿娩出后应用米索溶液直肠给药+缩宫素宫体肌内注射的产妇作为观察组,另外100例在剖宫产术中胎儿娩出后只应用缩宫素宫体肌内注射的产妇作为对照组,观察两组治疗结局。结果观察组术后出血量明显低于对照组(P<0.01)。结论米索与缩宫素联合用于预防和治疗产后出血安全、有效,可达到快速减少产后出血的目的。
Objective To investigate the clinical effect of using misoprostol (hereinafter referred to as misoprostol) to rapidly reduce bleeding after cesarean section. Methods 200 pregnant women with high risk factors for postpartum hemorrhage were selected. Among them, 100 cases were given cesarean solution rectally and oxytocin intramuscular injection as the observation group after fetus was delivered in cesarean section. The other 100 cases were Cesarean section after the fetus was delivered only the oxytocin Palace intramuscular injection of maternal as a control group, the treatment of two groups were observed. Results The postoperative bleeding in the observation group was significantly lower than that in the control group (P <0.01). Conclusion The combination of misoprostol and oxytocin for the prevention and treatment of postpartum hemorrhage is safe and effective, and the purpose of rapidly reducing postpartum hemorrhage can be reached.